Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $1.8 billion, employees in more than 60 countries, and more than 10,000 employees worldwide.

	NONCLINICAL DEVELOPMENT (Toxicology, Research Products, Analytical Services) Managed 443 compound development programs (>250 IND/CTA enabling), with over 100 different sponsors, which led to 41 IND/CTA applications in 2009 Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks Dedicated Capacity Agreements with several major pharma customers Greater than 2.5M sq ft of research space
;
	CLINICAL DEVELOPMENT (Clinical Pharmacology, Clinical, Central Labs) Supported 50% of latest breakthrough cancer treatments Supported development of the top 25 currently marketed medicines 70% of clinical programs on or ahead of enrollment timelines Broad-based, scalable and market-leading, Biomarker capability 99% of samples received within stability 145 million laboratory tests; 83,000 investigator sites; 100 countries Eight Clinical Pharmacology units with ~500 beds
	PERIAPPROVAL & MARKET ACCESS Results-driven reimbursement support for >60% of the biologics market Designed and managed world’s largest safety registry ever – iPledge Team of experts dedicated to risk management and Pharmacovigilance Bi-coastal call center capabilities to deliver patient and physician support